Sigma Healthcare Selloff Attracts New Bulls -- Market Talk

Dow Jones

2025/12/12

0020 GMT - Sigma Healthcare gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

December 11, 2025 19:20 ET (00:20 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2590754024"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2590754024\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2590754024?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-12 08:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590754024","market":"hk","top_or_hot":-1,"title":"Sigma Healthcare Selloff Attracts New Bulls -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0020 GMT - <a href=\"https://laohu8.com/S/SIGGF\">Sigma Healthcare</a> gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 11, 2025 19:20 ET (00:20 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sigma Healthcare Selloff Attracts New Bulls -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSigma Healthcare Selloff Attracts New Bulls -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-12-12 08:20</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0020 GMT - <a href=\"https://laohu8.com/S/SIGGF\">Sigma Healthcare</a> gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 11, 2025 19:20 ET (00:20 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4137","symbol_name":"綜合支持服務","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2590754024","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590754024","pubTimestamp":1765498800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0020 GMT - Sigma Healthcare gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4137":"综合支持服务","BK4588":"碎股","BK7103":"保健护理产品经销商","XLV":"健康照护类股ETF-SPDR","BK4585":"ETF&股票定投概念","HCSG":"Healthcare Svcs Group Inc","LABU":"三倍做多标普生物-Direxion","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK4581":"高盛持仓","SIG.AU":"SIGMA HEALTHCARE LTD","XBI":"SPDR S&P Biotech ETF"},"translate_title":"Sigma Healthcare抛售吸引了新的多头——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XLV":1.5,"LABU":0.6,"SIG.AU":0.9,"HCSG":1.5,"XBI":0.6},"content_text":"0020 GMT - Sigma Healthcare gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 11, 2025 19:20 ET (00:20 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}